Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Critical Outcome Technologies Inc V.COT

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  COTQF

Critical Outcome Technologies Inc is a biotechnology company. The Company is engaged in applying its proprietary computer-based technology, CHEMSAS, to identify and optimize drug candidates at early stage of preclinical drug development.
Price: $0.28 | Change: $0.00 | %Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 0.375/0.20
View modes: 
0 stars

RE:RE:RE:massive insider buying

RL1   it's been a long, long time coming, but I think it will be worth the wait.  rate and reply
0 stars

RE:RE:massive insider buying

sorry I didnt mean to post that multiple times...  overall about 400,000 or so on May 26 Something is going on, loads of buying coming in, and we have broken out over the 35 cent resistance from last...read more
0 stars

RE:massive insider buying

westlander168 wrote: there are massive insider buying! funny story, really don't understand . let's see what's happenning. May 26/15 May 26/15 Drake, John C. Control or Direction Common Shares 22 -...read more
0 stars

massive insider buying

there are massive insider buying! funny story, really don't understand . let's see what's happenning.  rate and reply
0 stars

going down

got out at 0.325.  This thing seems to be going down.  rate and reply
0 stars

RE:RE:Investigational New Drug Application With the FDA for COTI-2

I agree... big news.  Looks like rumour was out on Friday when we jumped up.   If we can close over 35 cents we can start a new leg up.  In any case great to see the progress being made...  rate and reply
0 stars

RE:Investigational New Drug Application With the FDA for COTI-2

COTi-2 IND Approval by FDA announced this morning.  This is a big step forward.  rate and reply
0 stars

Investigational New Drug Application With the FDA for COTI-2

Critical Outcome Technologies Files Investigational New Drug Application With the FDA for COTI-2 Novel p53-Dependent Cancer Therapy One Step Closer to the Clinic Monday, April 27, 2015...read more
0 stars

news april 2

LONDON, ON--(Marketwired - April 02, 2015) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") announced today it has retained Stonegate Capital Partners...read more
5 stars

COT filing IND is HUGE news.....

When the US boys catch wind of this there should be a pretty serious re rating for COT.   The next 3 months are going to be nail biters...... if this works... the sky is the limit!!  Dr. Danter and...read more
5 stars

Clinical Trial of COTI-2 in Recurrent Head and Neck Cancers

Critical Outcome Technologies Planning Phase 1 Clinical Trial of COTI-2 in Recurrent Head and Neck Cancers Company Signs Agreement With Dr. John Yoo of Western University for Continued Evaluation of...read more
0 stars

2015 PLI YEAR...

ALL IN PLI .... $1.95 right now.... GLTA and Haititrader too.... K7  rate and reply
5 stars

Successful Completion of Two-Species Toxicity Testing

this company doesn't have much of a following yet, but they do seem to be making great progress and doing everything right so far IMO Critical Outcome Technologies Reports Successful Completion of...read more
0 stars

COTI-2 in Treating Head and Neck Cancers

looks like more good news and progress........ Critical Outcome Technologies and MD Anderson Cancer Center to Evaluate COTI-2 in Treating Head and Neck Cancers Initial results suggest that COTI-2...read more
0 stars

RE:no difference

be great to have a US listing but I think they have been getting their profile raised in the US lately... new investors etc.   Hopefullly can keep making progress on that.  rate and reply
0 stars

Present at 13th Annual BIO Investor Forum on Tuesday

Critical Outcome Technologies to Present at 13th Annual BIO Investor Forum on Tuesday, October 7, 2014 Significant Impact of COTI-2's p53-dependent Mechanism of Action on Cancer to Be Highlighted...read more
0 stars

no difference

we have to move away from canadian markets go usa or anywhere but canada we spin are wheels at best at worst we go down  rate and reply
0 stars

COTI-2, Receives Sixth U.S. Patent and First Japanese Patent

Critical Outcome's Lead Cancer Drug Candidate, COTI-2, Receives Sixth U.S. Patent and First Japanese Patent Additional Patents Further Enhance the Value of COTI-2 Friday, October 03, 2014...read more
1 star

RE:RE:Key commercialization initiatives advanced during fiscal2014

  rate and reply
0 stars

COTI-2: Potent Anti-Cancer P53-Dependent Activity

Selective and Potent Anti-Cancer P53-Dependent Activity Demonstrated by Critical Outcome's COTI-2 Company Completes Definitive Experiments With Its Lead Cancer Drug Wednesday, September 10, 2014 ...read more